Plain-English translation of NCT03267615 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The VICIS study is a long-term research project that carefully monitors people with advanced liver disease (cirrhosis). Researchers will track your health over time with regular clinic visits, imaging scans, blood tests, and optional tissue samples. The goal is to understand which patients are at highest risk for serious complications and to find better ways to predict and prevent them.
Right now, doctors struggle to predict which patients with cirrhosis will develop life-threatening complications like bleeding, fluid buildup, or brain damage. This study aims to collect detailed information from thousands of patients to identify warning signs and improve how we care for people with advanced liver disease.
You likely qualify if…
You likely don't qualify if…
You will visit the cirrhosis clinic at Vienna General Hospital every 3 to 6 months depending on the stage of your disease. At each visit, you'll have blood work, imaging scans, and a physical exam to check for new complications. You may also be asked to donate optional samples — blood, urine, or tissue — which researchers will store for future study. The clinic staff will also ask you detailed questions about your health, medications, and lifestyle to build a complete picture of how your disease changes over time.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Austria
Enrollment target
~10,000 participants
Started
February 2017
Primary completion
December 2026
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas Reiberger, M.D.
Medical University of Vienna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.